ERIS Lifesciences Ltd (ERIS) — Board Meeting | 21 September 2026
ERIS Lifesciences announced the appointment of Akhil Awasthi as an additional non-executive independent director effective September 26, 2026, for a five-year term, subject to shareholder approval, following board recommendation and compliance with SEBI listing regulations.
About ERIS Lifesciences Ltd (ERIS)
Healthcare · Pharmaceuticals · Listed on BSE
📡 Get AI alerts when ERIS files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track ERIS — Free💡 Ask AI about this filing
📊 More ERIS filings
- Announcement — 28 September 2026ERIS Lifesciences announced that its trading window will close on October 1, 2026, and remain shut u...
- 🟡 Board Meeting — 25 September 2026ERIS Lifesciences held its 20th AGM on 25 September 2026 via video conference, approving audited fin...
- 🟡 Board Meeting — 25 September 2026ERIS Lifesciences held its 20th AGM on 25 September 2026 via video conference, approving the audited...
- 🔴 Corporate Action — 22 September 2026ERIS Lifesciences announced the allotment of 155,264 equity shares under its ESOP-2021 scheme on Sep...
- 🟡 Board Meeting — 11 September 2026ERIS Lifesciences announced the resignation of Executive Director and COO Krishnakumar Vaidyanathan ...
🔥 Also filed on 21 September 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when ERIS files new disclosures
Track ERIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track ERIS — FreeFree account · 2 AI queries/day